| 1002-5 | DBG Ab (qualitative) |
| 100281-5 | D Ab |
| 1003-3 | Indirect antiglobulin test.complement specific reagent (qualitative) |
| 100351-6 | Pioglitazone (qualitative) |
| 100352-4 | Rosiglitazone (qualitative) |
| 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma (lc/ms/ms) |
| 100372-2 | Abiraterone |
| 100424-1 | 8(9)-Cholestenol |
| 100425-8 | DiHydro T-Mas |
| 100426-6 | Squalene |
| 100427-4 | Stigmasterol |
| 1005-8 | Indirect antiglobulin test.IgG specific reagent (qualitative) |
| 100662-6 | Cortisol free and total panel - Serum or Plasma |
| 100677-4 | Epstein Barr virus DNA (viral load) (naa with probe detection) |
| 100679-0 | Herpes virus 6 DNA (viral load) (naa with probe detection) |
| 100681-6 | Herpes virus 7 DNA (viral load) (naa with probe detection) |
| 100683-2 | Herpes virus 8 DNA (viral load) (naa with probe detection) |
| 100685-7 | JC virus DNA (viral load) (naa with probe detection) |
| 100689-9 | Toxoplasma gondii DNA (naa with probe detection) |
| 100712-9 | Brexpiprazole |
| 100713-7 | Cariprazine |
| 100714-5 | Guanfacine |
| 100715-2 | Prothipendyl |
| 100737-6 | Alkaline phosphatase.macromolecular (qualitative) |
| 100738-4 | Alanine aminotransferase.macromolecular (qualitative) |
| 100739-2 | Aspartate aminotransferase.macromolecular (qualitative) |
| 100740-0 | Amylase.macromolecular (qualitative) |
| 100741-8 | Gamma glutamyl transferase.macromolecular (qualitative) |
| 100742-6 | Lactate dehydrogenase.macromolecular (qualitative) |
| 100743-4 | Lipase.macromolecular (qualitative) |
| 100744-2 | Alpha-1-acid glycoprotein (electrophoresis) |
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
| 100755-8 | Oligoclonal bands (isoelectric focusing) |
| 1008-2 | Indirect antiglobulin test.polyspecific reagent (qualitative) |
| 100816-8 | Glucagon --6th specimen post XXX challenge |
| 100817-6 | Glucagon --7th specimen post XXX challenge |
| 100830-9 | Alpha subunit free --1st specimen post XXX challenge |
| 100831-7 | Alpha subunit free --2nd specimen post XXX challenge |
| 100832-5 | Alpha subunit free --3rd specimen post XXX challenge |
| 100833-3 | Alpha subunit free --4th specimen post XXX challenge |
| 100834-1 | Alpha subunit free --5th specimen post XXX challenge |
| 100835-8 | Alpha subunit free --6th specimen post XXX challenge |
| 100836-6 | Alpha subunit free --7th specimen post XXX challenge |
| 100837-4 | Insulin-like growth factor-I --9th specimen post XXX challenge |
| 100838-2 | Testosterone --9th specimen post XXX challenge |
| 100839-0 | Vitamin A/Retinol binding protein |
| 100842-4 | Nonalcoholic steatohepatitis score Calculated (fast) |
| 100843-2 | Liver fibrosis score (calculated.agile3+) |
| 100844-0 | Liver fibrosis score (calculated.agile4) |
| 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab (qualitative, immunoassay) |
| 100891-1 | Orthopoxvirus IgG Ab (qualitative, immunoassay) |
| 100892-9 | Orthopoxvirus IgM Ab (qualitative, immunoassay) |
| 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
| 100898-6 | Lipid panel - Serum or Plasma |
| 100914-1 | Protein.abnormal band (electrophoresis) |
| 100963-8 | Dengue virus 1+2+3+4 nsP1 IgG Ab (immunoassay) |
| 100976-0 | Eosinophil derived neurotoxin |
| 100977-8 | JC virus Ab Index (immunoassay) |
| 100978-6 | Thyroxine.free.gestational (immunoassay) |
| 100998-4 | Cortisol post dose insulin IV panel - Serum or Plasma |
| 100999-2 | Somatotropin post dose insulin IV panel - Serum or Plasma |
| 101060-2 | An^a Ab (qualitative) |
| 101061-0 | Be^a Ab (qualitative) |
| 101062-8 | BARC Ab (qualitative) |
| 101063-6 | Co3 Ag Ab (qualitative) |
| 101065-1 | Co4 Ab (qualitative) |
| 101066-9 | Cr^a Ab (qualitative) |
| 101067-7 | Cs^b Ab (qualitative) |
| 101069-3 | CE Ab (qualitative) |
| 101070-1 | CEAG Ab (qualitative) |
| 101071-9 | CELO Ab (qualitative) |
| 101072-7 | CENR Ab (qualitative) |
| 101073-5 | CEST Ab (qualitative) |
| 101074-3 | CEVF Ab (qualitative) |
| 101075-0 | Crawford Ab (qualitative) |
| 101076-8 | Dh^a Ab (qualitative) |
| 101077-6 | Dr^a Ab (qualitative) |
| 101078-4 | D(sup)w Ab (qualitative) |
| 101079-2 | DAK Ab (qualitative) |
| 101080-0 | En^a Ab (qualitative) |
| 101081-8 | Es^a Ab (qualitative) |
| 101082-6 | Evans Ab (qualitative) |
| 101083-4 | Fy5 Ab (qualitative) |
| 101084-2 | FPTT Ab (qualitative) |
| 101085-9 | Ge1 Ab (qualitative) |
| 101086-7 | Ge2 Ab (qualitative) |
| 101088-3 | Ge3 Ab (qualitative) |
| 101090-9 | Ge4 Ab (qualitative) |
| 101091-7 | Hr^s Ab (qualitative) |
| 101092-5 | Hr^B Ab (qualitative) |
| 101093-3 | Hut Ab (qualitative) |
| 101094-1 | In^a Ab (qualitative) |
| 101095-8 | IFC Ab (qualitative) |
| 101096-6 | Jo sup(a) Ab (qualitative) |
| 101097-4 | JAHK Ab (qualitative) |
| 101099-0 | Km Ab (qualitative) |
| 101101-4 | Kx Ab (qualitative) |
| 101103-0 | C^G Ab (qualitative) |
| 101132-9 | Glucose post XXX challenge panel - Serum or Plasma |
| 101137-8 | MNS29 (qualitative) |